
Sign up to save your podcasts
Or


Dr. Cohen explains how PSMA-targeted imaging and radioligand therapy work together to identify and treat prostate cancer with greater precision. The discussion covers which patients may be candidates for these therapies, how treatment decisions are made, and what emerging research may mean for future care.
By Mass Prostate Cancer Coalition5
77 ratings
Dr. Cohen explains how PSMA-targeted imaging and radioligand therapy work together to identify and treat prostate cancer with greater precision. The discussion covers which patients may be candidates for these therapies, how treatment decisions are made, and what emerging research may mean for future care.

57 Listeners